Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE - Nasdaq Real Time Price USD

Enhabit, Inc. (EHAB)

8.20
+0.16
+(1.99%)
At close: May 7 at 4:00:02 PM EDT
7.85
-0.35
(-4.27%)
Pre-Market: 4:13:49 AM EDT
Loading Chart for EHAB
  • Previous Close 8.04
  • Open 8.13
  • Bid 8.56 x 800
  • Ask --
  • Day's Range 8.01 - 8.25
  • 52 Week Range 6.85 - 10.70
  • Volume 384,273
  • Avg. Volume 331,701
  • Market Cap (intraday) 415.227M
  • Beta (5Y Monthly) 1.21
  • PE Ratio (TTM) --
  • EPS (TTM) -3.11
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 9.00

Enhabit, Inc. provides home health and hospice services in the United States. The company's home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. It also provides hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

www.ehab.com

10,700

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EHAB

View More

Performance Overview: EHAB

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EHAB
4.99%
S&P 500 (^GSPC)
4.26%

1-Year Return

EHAB
17.17%
S&P 500 (^GSPC)
8.55%

3-Year Return

EHAB
67.20%
S&P 500 (^GSPC)
36.57%

5-Year Return

EHAB
67.20%
S&P 500 (^GSPC)
95.45%

Compare To: EHAB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EHAB

View More

Valuation Measures

Annual
As of 5/7/2025
  • Market Cap

    415.23M

  • Enterprise Value

    956.33M

  • Trailing P/E

    --

  • Forward P/E

    22.27

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.40

  • Price/Book (mrq)

    0.79

  • Enterprise Value/Revenue

    0.92

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.09%

  • Return on Assets (ttm)

    2.19%

  • Return on Equity (ttm)

    -24.53%

  • Revenue (ttm)

    1.03B

  • Net Income Avi to Common (ttm)

    -156.2M

  • Diluted EPS (ttm)

    -3.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.4M

  • Total Debt/Equity (mrq)

    102.87%

  • Levered Free Cash Flow (ttm)

    48.31M

Research Analysis: EHAB

View More

Company Insights: EHAB

Research Reports: EHAB

View More

People Also Watch